Friday, 27 November 2020   Subscription to updates  RSS
Friday, 27 November 2020   Subscription to updates  RSS
5:01, 28 November 2017

Bench to Bedside: Ocular Drug Delivery – Robert Bhisitkul and Tejal Desai (UCSF) Age related macular degeneration (AMD) is one of several retinal diseases that can lead to vision loss and, ultimately, blindness. Dr. Bhisitkul explains that the class of anti-VEGF biologic drugs (Lucentis, Avastin, Eylea) can treat AMD, however, ongoing, monthly injections into the eye are required for the drugs to be fully effective. There are a number of drawbacks to this treatment regime, many of which could be mitigated by the development of a drug delivery device for implantation in the eye. Dr. Desai describes the work done in her lab to develop an injectable, biocompatible and biodegradable device that has the right release kinetics to successfully deliver needed drugs to the retina of patients with AMD.From: iBiology


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2020 News: Today's News Headlines, Breaking News & Recent News from the World
Дизайн и поддержка: